High dose chemotherapy with autologous stem cell support for patients with histologically transformed B‐cell non‐Hodgkin lymphomas. A Norwegian multi centre phase II study

No abstract is available for this paper.

• Publication year

  2011

• Venue

  British Journal of Haematology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2010.08519.xPMID 21241276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The incidence, natural history, biology, and treatment of transformed lymphomas.

  2009influential reference
• Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

  2008cited by this paper
• Early Lymphocyte Recovery Predicts Superior Survival after Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation for Patients with Hematological Malignancies.

  2008cited by this paper
• AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

  2008cited by this paper
• High‐dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B‐cell lymphoma

  2008cited by this paper
• Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study.

  2008cited by this paper
• Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.

  2008cited by this paper
• Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma

  2007cited by this paper
• A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma.

  2007cited by this paper
• Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study

  2007cited by this paper
• Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.

  2007cited by this paper
• Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation

  2006cited by this paper
• Follicular lymphoma international prognostic index

  2006cited by this paper
• The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.

  2006cited by this paper
• Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

  2005cited by this paper
• Infused CD34+ cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B‐cell lymphoma and follicular lymphoma grade 3 treated with high‐dose therapy

  2004cited by this paper
• The epidemiology of non-Hodgkin's lymphoma

  2004cited by this paper
• Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

  2003cited by this paper
• Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma

  2003cited by this paper
• Poor Mobilization of Peripheral Blood Stem Cells is a Risk Factor for Worse Outcome in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

  2003cited by this paper
• High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial.

  2003cited by this paper
• Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.

  2003cited by this paper
• blood stem cell transplantation for chronic lymphoproliferative disorders: High purging efficiency but increased risk of severe infections

  2002cited by this paper
• Autologous bone marrow transplants.

  2002cited by this paper
• High-dose therapy in patients with Hodgkin's disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells

  2001cited by this paper
• Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

  2001cited by this paper
• Autotransplants for histologically transformed follicular non‐Hodgkin's lymphoma

  2001cited by this paper
• High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.

  2001influential reference
• Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients.

  2001cited by this paper
• High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.

  2001cited by this paper
• Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer.

  2000cited by this paper
• Long‐term follow‐up of autologous stem‐cell transplantation for follicular and transformed follicular lymphoma

  2000cited by this paper
• Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation

  2000cited by this paper
• International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.

  1999cited by this paper
• Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.

  1999influential reference
• International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.

  1999cited by this paper
• Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

  1998cited by this paper
• High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre.

  1998cited by this paper
• Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.

  1998cited by this paper
• Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin’s and non-Hodgkin’s lymphoma

  1998cited by this paper
• Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

  1997cited by this paper
• Purging of Tumor Cells from Leukapheresis Products: Experimental and Clinical Aspects

  1996cited by this paper
• Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry.

  1996cited by this paper
• The epidemiology of non-Hodgkin's lymphoma.

  1996cited by this paper
• Long-term survival after histologic transformation of low-grade follicular lymphoma.

  1995influential reference
• Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

  1995cited by this paper
• Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma.

  1995cited by this paper
• Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma.

  1994cited by this paper
• Autologous bone marrow transplantation

  1993cited by this paper
• Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.

  1989cited by this paper
• The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

  1984cited by this paper
• An autopsy study of histologic progression in non‐Hodgkin's lymphomas 192 cases from the national cancer institute

  1983cited by this paper
• Histologic conversion in the non-Hodgkin's lymphomas.

  1983cited by this paper

• Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study

  2025cites this paper
• Outcomes of hematopoietic cell transplantation for transformed follicular lymphoma

  2021cites this paper
• Follicular lymphoma : clinical and biological factors associated with response to therapy and overall prognosis

  2020cites this paper
• Pannexin-1 channel “fuels” by releasing ATP from bone marrow cells a state of sterile inflammation required for optimal mobilization and homing of hematopoietic stem cells

  2020cites this paper
• Clinical Characteristics, Treatment Pattern and Outcome of Histologic Transformed Lymphoma, a Single Institution Experience

  2019cites this paper
• Impact of Concurrent Indolent Lymphoma on the Clinical Outcome of Newly Diagnosed Diffuse Large B-Cell Lymphoma.

  2019cites this paper
• Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.

  2017cites this paper
• Transformed follicular lymphoma (tFL): consolidation therapy may improve survival

  2017cites this paper
• Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High Dose BEAM for Non-Hodgkin Lymphoma: The Role of Histology

  2017cites this paper
• The role of stem cell transplantation in follicular lymphoma.

  2017cites this paper
• Innate Immunity and Mobilization of Hematopoietic Stem Cells

  2017cites this paper
• Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013

  2017cites this paper
• Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

  2016cites this paper
• Hematopoietic Cell Transplantation for Non'Hodgkin Lymphoma (B Cell)

  2016cites this paper
• Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma.

  2016cites this paper
• Potential New Drugs in Lymphoma

  2016cites this paper
• Autologous Stem Cell Transplantation for Transformed Lymphoma: Single-Center Experience

  2016cites this paper
• Potential New Drugs in Lymphoma

  2016cites this paper
• Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12.

  2015influential citation
• 18F-FDG or 3′-Deoxy-3′-18F-Fluorothymidine to Detect Transformation of Follicular Lymphoma

  2015cites this paper
• Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis

  2015cites this paper
• Treatment of patients with transformed lymphoma.

  2015cites this paper
• Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation.

  2015cites this paper
• From THE DEPARTMENT OF LABORATORY MEDICINE Karolinska Institutet, Stockholm, Sweden GENETICS OF DIFFUSE LARGE B-CELL LYMPHOMA

  2015influential citation
• Stem cell transplantation in follicular lymphoma

  2015cites this paper
• Transformed follicular non-Hodgkin lymphoma.

  2015cites this paper
• Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

  2014cites this paper
• Allogeneic hematopoietic stem cell transplantation for aggressive lymphomas

  2014cites this paper
• Transformed Follicular Lymphoma: Is Early Autologous Stem Cell Transplantation Indicated in the Modern Era?

  2014cites this paper
• Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimen.

  2014cites this paper
• Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy

  2014cites this paper
• Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.

  2014cites this paper
• High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era

  2014cites this paper
• Autologous hematopoietic cell transplantation: An update for clinicians

  2014cites this paper
• Improving the outcome of patients with lymphoproliferative disorders

  2014cites this paper
• 106 – Non-Hodgkin Lymphoma

  2014cites this paper
• High-Dose Chemotherapy with Autologous Stem Cell Support in the Treatment of Transformed B-Cell Non-Hodgkin’s Lymphomas

  2013cites this paper
• Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation.

  2013influential citation
• High-dose therapy with autologous stem cell support for lymphoma--from experimental to standard treatment.

  2013cites this paper
• Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?

  2013cites this paper
• Stem cell transplantation for non-hodgkin's lymphomas

  2013cites this paper
• Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

  2013influential citation
• Transformed non‐Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database

  2013cites this paper
• High-dose therapy with autologous stem cell support for lymphoma – from experimental to standard treatment

  2012cites this paper
• Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.

  2012cites this paper
• High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era

  2012cites this paper
• What is the role of transplantation for indolent lymphoma?

  2012cites this paper
• Transformation in Follicular Lymphoma: Biology, Prognosis, and Therapeutic Options

  2012cites this paper
• Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Follicular Lymphoma

  2012cites this paper
• Heading for Springerlink: Lymphomas (PA Hamlin, Section Editor) Transformation in Follicular lymphoma: Biology, prognosis, and therapeutic options

  2012cites this paper
• Controversies and Recent Advances in Hematopoietic Cell Transplantation for Follicular Non-Hodgkin Lymphoma

  2012cites this paper
• Is autologous stem cell transplantation for transformed follicular lymphoma still justifiable?

  2012cites this paper
• Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with 90Yttrium ibritumomab tiuxetan‐BEAM and autologous stem cell transplantation

  2012cites this paper